rs1131692053
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_ModeratePP5_Moderate
The NM_005921.2(MAP3K1):c.634-8T>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_005921.2 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP3K1 | NM_005921.2 | c.634-8T>A | splice_region_variant, intron_variant | Intron 2 of 19 | ENST00000399503.4 | NP_005912.1 | ||
MAP3K1 | XM_047417218.1 | c.634-8T>A | splice_region_variant, intron_variant | Intron 2 of 17 | XP_047273174.1 | |||
MAP3K1 | XM_047417219.1 | c.223-8T>A | splice_region_variant, intron_variant | Intron 3 of 20 | XP_047273175.1 | |||
MAP3K1 | XM_047417220.1 | c.223-8T>A | splice_region_variant, intron_variant | Intron 3 of 20 | XP_047273176.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP3K1 | ENST00000399503.4 | c.634-8T>A | splice_region_variant, intron_variant | Intron 2 of 19 | 1 | NM_005921.2 | ENSP00000382423.3 | |||
ENSG00000237705 | ENST00000415589.1 | n.298A>T | non_coding_transcript_exon_variant | Exon 2 of 4 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
46,XY sex reversal 6 Pathogenic:2
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0101 - Gain of function is a known mechanism of disease in this gene and is associated with 46,XY sex reversal 6 (MIM#613762) (PMIDs: 21129722, 24135036, 30608580). (I) 0107 - This gene is associated with autosomal dominant disease. However, it is sex-limited in that only 46XY individuals are affected (GeneReviews). (I) 0115 - Variants in this gene are known to have variable expressivity. Intra- and inter-familial variability have been reported (PMIDs: 27899157, 12476449, 21129722). (I) 0210 - Splice site variant proven to affect splicing of the transcript with a known effect on protein sequence. RNA analysis from affected individuals demonstrated presence of an aberrant transcript containing an insertion of 6bp, predicted to result in p.(Val211_Val212insIleGln) (PMID: 21129722). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0600 - Variant is located in the annotated GEF domain (PMID: 30608580). (I) 0803 - This variant has limited previous evidence of pathogenicity in an unrelated individual. It has been identified in a large multi-generational French family (PMID: 21129722). (SP) 0901 - This variant has strong evidence for segregation with disease. Five heterozygous affected individuals were identified in a large multi-generational family. The other affecteds were not genotyped (PMID: 21129722). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at